Avtr.K

The company's capital structure is characterized by a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. Its liquidity position is marked by a current ratio of 1.78, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -248.8 million USD, which may limit its ability to fund operations and growth without external financing.

Profitability metrics reveal a challenging financial situation for AVTR.K. The company reported a net loss of 530.2 million USD and an operating loss of 250.8 million USD, indicating that it is not currently generating positive operating income. The return on equity (ROE) is -9.53%, and the return on assets (ROA) is -4.5%, both of which are significantly below the industry median for the Medical Equipment, Supplies & Distribution sector.

AVTR.K's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification in the provided data. This concentration may expose the company to specific market risks within the healthcare sector, such as regulatory changes or shifts in demand for medical equipment and supplies.

The company's growth trajectory is uncertain, as it is currently reporting a net loss and negative operating income. Analysts have provided a mean price target of 10.04 USD, which is higher than the current market price of 8.43 USD, suggesting some optimism about the company's future performance. However, the company's free cash flow is negative, which may hinder its ability to invest in growth initiatives without additional financing.

The risk assessment for AVTR.K indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which may affect its ability to meet short-term obligations. The dilution risk is low, suggesting that the company is not expected to issue a significant number of new shares in the near term.

Recent events and filings have not been provided in the input data, so no specific recent developments can be cited for AVTR.K.

Avantor Inc (AVTR.K) has recorded a major modification in its holder profile, marking the most significant recent activity for the ticker. This change involves a substantial reduction in shareholding by investor ID 587, whose position dropped from 47,140 shares to just 17 shares. The adjustment was detected on June 21, 2026, and reflects a dramatic shift in the investor's exposure to the company. The financial impact of this divestment is notable, with the value of the holding decreasing from $0.369 million to $0.000133 million. Consequently, the investor's weight in the portfolio plummeted from 0.000213% to a negligible 7.68e-08%. This near-total exit suggests a decisive move by the holder to liquidate their stake in Avantor. This event represents the first analysis for this ticker, meaning there is no prior basis for computing delta changes against historical trends. As such, this holder modification stands as the primary data point for assessing recent activity, rather than part of a continuing pattern of accumulation or distribution. Avantor Inc currently maintains a corporate structure with one officer and 34 top holders, though it has no analyst coverage or index membership. The absence of analyst estimates or index inclusion limits broader market context, making the specific holder changes, such as the one by investor ID 587, particularly relevant for tracking ownership dynamics.